Contact us for a free legal consultation about your Avandia lawsuit
Since the news broke about Avandia’s link to serious health complications, many patients have considered filing Avandia lawsuits.
If you’re thinking about an Avandia lawsuit, contact the unsafe drug litigation attorneys at Anapol Schartz for a free evaluation of your case.
More About Avandia :
» Avandia Resources on the Web
In May of 2007, the New England Journal of Medicine published the startling news that Avandia, a popular drug designed to control Type II Diabetes, substantially increases patients’ risk of serious heart problems.
The study found that patients taking Avandia increased their risk of heart attacks by 43 percent and their risk of death from heart disease by up to 64 percent. This news is especially disturbing because diabetes itself already raises its victims’ risk of serious heart disease substantially. Two of three diabetics die of cardiovascular problems, according to the American Diabetes Association. According to a report by the U.S. Food and Drug Administration, Avandia has caused at least 83,000 “excess” heart attacks since it entered the market.
In response to the Journal’s report, the FDA ordered GlaxoSmithKline, Avandia’s manufacturer, to include a “black box” safety warning on the drug’s label. The FDA did not order a recall, nor did GlaxoSmithKline recall Avandia voluntarily. However, the FDA’s May 2007 safety warning said GlaxoSmithKline’s own analysis -- provided only after the Journal’s report -- found that Avandia raised patients’ risk of heart attack by 30 to 40 percent. And a medical expert on diabetes testified to Congress that Avandia’s manufacturer threatened to sue him when he called attention to heart problems among Avandia users.
The risk of heart attack or heart-related death among Avandia users is greatest in patients who are already being treated for heart failure or at high risk of heart problems. The drug is also not recommended for people with liver disease or pregnant or nursing women. The FDA suggests that these patients speak to their doctors about finding another way to control their blood-sugar levels. However, there is a risk even for patients without these conditions. Patients taking Avandia are advised to call a doctor immediately if they notice any of these symptoms:
At the time of the announcement, Avandia was used by about 1 million of the estimated 20 million Type II diabetics in the United States, generating a total of $2.2 billion in sales in 2006. Since these serious safety concerns about the drug have emerged, however, many patients have stopped taking Avandia and sales have fallen. And in the face of growing evidence that GlaxoSmithKline knew about the safety risks of Avandia well before they were made public, thousands of patients and their loved ones have considered filing an Avandia lawsuit in order to publicize Avandia’s risks, win compensation for a wrongful death, medical bills or serious health problems, or remove this dangerous drug from the market.
Verdicts & Settlements |
Anapol TV |
Our Attorneys |
About Us |
Contact Us |
Site Map |
Avandia Lawsuits Site Map
Philadelphia, PA - Cherry Hill, NJ - Media, PA - Reading, PA - Harrisburg, PA
Copyright © - Anapol Schwartz - Pennsylvania Avandia Attorneys - Philadelphia Avandia Law Firm. All rights reserved.
Philadelphia Avandia Attorney Disclaimer: This website is dedicated to providing public information regarding Avandia and other legal information. None of the information on this site is intended to be formal legal advice, nor the formation of a lawyer or attorney client relationship. Please contact a Central Pennsylvania personal injury attorney or New Jersey Avandia lawyer at our law firm for information regarding your particular case. This website is not intended to solicit clients outside the States of New Jersey and Pennsylvania.